The Phase 3 SOLARIS trial showed symptom improvement and better personal and social functioning. WELTRUZA will be available in three strengths in coming weeks.
Beyond Nigeria, concerns over Ebola and declining malaria financing also kept regional health security in focus.
Prioritize the high-burden US market, differentiated therapies, secondary prevention, strategic partnerships, and access-focused pricing to boost adoption and ROI.Dublin, Oct. 07, 2026 (GLOBE NEWSWIRE ...
Full one-year results from the KYSA-8 registrational trial in stiff person syndrome to be reported, demonstrating sustained clinical benefit and ...
Access in-depth financial information about Unit Linked Insurance NAV and related insurance policies. Stay ahead with updates and insights on financial insurance products at Rediff MoneyWiz.
Background Heart failure (HF) remains associated with high mortality worldwide despite advances in guideline-directed therapy ...
GRAILto Present Six Abstracts at the Early Detection of Cancer Conference (EDCC) Spanning Clinical Performance, Health Equity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results